Robert Ang

Title: The Innovations of Robert Ang

Introduction

Robert Ang is an accomplished inventor based in Cupertino, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. With a total of 3 patents to his name, Ang's work focuses on innovative compositions that aim to improve the quality of life for individuals suffering from Alzheimer's Disease and other forms of dementia.

Latest Patents

Ang's latest patents disclose compositions containing glibenclamide and NSC antagonists, which are useful in the treatment, prevention, and delay of dementia onset. These compositions may be administered alone or in combination with other drugs used for treating dementia. Additionally, they can be combined with drugs that stabilize or increase blood plasma glucose levels. The pharmaceutical compositions and dosage forms are designed to provide stable plasma levels for extended periods. Notable examples include combinations of glibenclamide with memantine or donepezil, as well as tolbutamide with these dementia drugs.

Career Highlights

Robert Ang is currently associated with Biogen Chesapeake LLC, where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing new treatment options for dementia, showcasing his commitment to addressing critical health challenges.

Collaborations

Ang collaborates with various professionals in the field, including his coworker Sven Jacobson, to enhance the effectiveness of his inventions and broaden their impact.

Conclusion

Robert Ang's contributions to the field of dementia treatment through his innovative patents highlight his dedication to improving patient outcomes. His work at Biogen Chesapeake LLC continues to pave the way for advancements in pharmaceutical compositions aimed at combating dementia.